HIV Prevention Strength Training
Building Skills in PrEP Implementation
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women.
Bekker, et al. N Engl J Med. 2024;391(13):1179-1192.
Inclusion of pregnant and lactating people in the PURPOSE 1 study: efficacy, safety, and pharmacokinetics.
Bekker LG, Moodley D, Harkoo I, Kigozi G, Louw CE, Malahleha M, et al. IAS conference; July 13-17, 2025; Kagli, Rwanda. Abstract OAC0505.
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
Celum C, Hosek S, Tsholwana M, et al. PLoS Med. 2021;18(6):e1003670.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Delany-Moretlwe S, et al. Lancet. 2022;399(10337):1779-1789.
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
Delany-Moretlwe S, Hanscom B, Guo X, et al. J Int AIDS Soc. 2025;28(1):e26401.
Shared risk factors among women for intimate partner violence in the United States: a secondary analysis.
Güler A, Lambert J, Rojas-Guyler L, et al. Violence Against Women. 2024;30(1):3-30.
Emtricitabine/tenofovir alafenamide.
HIV.gov. Drug database.
Emtricitabine/tenofovir disoproxil fumarate.
HIV.gov. Drug database.
Cabotegravir.
HIV.gov. Drug database.
Lenacapavir.
HIV.gov. Drug database.
Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension.
Kamya MR, Balzer LB, Ayieko J, et al. Lancet HIV. 2024;11(11):e736-e745.
Estimating the population need for preexposure prophylaxis for HIV in the United States.
Kourtis AP, Wiener J, Zhu W, et al. Ann Epidemiol. 2025;106:48-54.
Problem-based shared decision making: the role of canonical SDM steps.
Montori VM, Ruissen MM, Branda ME, Hargraves IG, Kunneman M. Health Expect. 2023;26(1):282-289.
PrEP ACCESS, ASSISTANCE, AND INFORMATION
Patient and Provider assistance: PleasePrEPMe.org.
Information about PrEP, nPEP, insurance and insurance rights, finding a PrEP/nPEP provider, and a list of PrEP resources by state
Provider assistance: AETC; AIDS Education & Training Center Program: National Coordinating Resource Center
Supports national HIV priorities by providing training, consultation, and resources
Patient assistance (without insurance).
The PrEP patient assistance program will provide medication at no cost for those who meet income guidelines.
Uninsured 24/7 support online, by phone during business hours and fax enrollment
Copay assistance (for patients with nongovernment insurance).
Phone number: 1-800-226-2056
Copay assistance/out-of-pocket costs.
ViiV Connect.
Clinical Practice Guidelines
Sexually transmitted infections treatment guidelines. 2021.
Centers for Disease Control and Prevention (CDC). Last reviewed July 2021.
Status neutral HIV care and service delivery: eliminating stigma and reducing health disparities.
CDC
Clinical guidance for PrEP.
CDC.
Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel.
Gandhi RT, et al. JAMA. 2025;333(7):609-628.
Preexposure prophylaxis for HIV: updated recommendations from the 2024 International Antiviral Society-USA Panel.
Landovitz RJ, et al. JAMA. 2025. Epub ahead of print.
Trauma-informed approaches toolkit.
National Alliance of State & Territorial AIDS Directors (NASTAD).
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
Final Recommendation Statement. Prevention of Acquisition of HIV: Preexposure Prophylaxis.
U.S. Preventive Services Task Force. 2023.
Professional Organizations & Resources
HealthHIV.
HIV Prevention Certified Provider™ Certification Program.
American Academy of HIV Medicine.
HIV Nexus: CDC Resources for Clinicians.
Centers for Disease Control and Prevention.
National Clinician Consultation Center.
University of California, San Francisco; 2023.
HIV drug interactions.
University of Liverpool (website); updated October 2023.
PrEP implementation checklists.
PrEPWatch.
Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), and Other HIV Prevention Strategies Billing and Coding Guide; October 2023.
NASTAD.
HIV Prevention in OB/GYN Care
Women, PrEP, and Sexual Health
| Faculty: | Charlotte-Paige Rolle, MD, MPH |
| Release: | 10/24/2025 |
| Expiration: | 10/24/2026 |
